Literature DB >> 19003044

Preparation of cationic immunovesicles containing cationic Peptide lipid for specific drug delivery to target cells.

Takuya Sugahara1, Shinichi Kawashima, Akiko Oda, Yoshio Hisaeda, Keiichi Kato.   

Abstract

The cationic vesicle composed of Span80 and cationic peptide lipid (CPL) was prepared. The cytotoxicity of the Span80-CPL cationic vesicle was very low compared with Span80 vesicle. Antibody was able to be immobilized on vesicle surface by mediation of protein A. The antigen targeting ability of the antibody-immobilized vesicle (immunovesicle) derived from antibody was evaluated. Our results suggested that the Span80-CPL immunovesicles specifically associate with target cells by the antibody mediation, and the substance capsulated in immunovesicle was transferred into the target cells. This means that the Span80-CPL immunovesicle is expected to achieve a high local concentration of an encapsulated drug at the target.

Entities:  

Year:  2005        PMID: 19003044      PMCID: PMC3449823          DOI: 10.1007/s10616-005-3764-5

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  7 in total

1.  Investigation of the cellular uptake of E-Selectin-targeted immunoliposomes by activated human endothelial cells.

Authors:  S Kessner; A Krause; U Rothe; G Bendas
Journal:  Biochim Biophys Acta       Date:  2001-10-01

Review 2.  Immunoliposomes: a promising approach to targeting cancer therapy.

Authors:  G Bendas
Journal:  BioDrugs       Date:  2001       Impact factor: 5.807

3.  The cytotoxic effect of Eucheuma serra agglutinin (ESA) on cancer cells and its application to molecular probe for drug delivery system using lipid vesicles.

Authors:  T Sugahara; Y Ohama; A Fukuda; M Hayashi; A Kawakubo; K Kato
Journal:  Cytotechnology       Date:  2001-07       Impact factor: 2.058

4.  Growth of hybridoma cells in serum-free medium: ethanolamine is an essential component.

Authors:  H Murakami; H Masui; G H Sato; N Sueoka; T P Chow; T Kano-Sueoka
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

5.  Immunoliposomes bearing polyethyleneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo.

Authors:  K Maruyama; N Takahashi; T Tagawa; K Nagaike; M Iwatsuru
Journal:  FEBS Lett       Date:  1997-08-11       Impact factor: 4.124

6.  Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.

Authors:  John W Park; Keelung Hong; Dmitri B Kirpotin; Gail Colbern; Refaat Shalaby; Jose Baselga; Yvonne Shao; Ulrik B Nielsen; James D Marks; Dan Moore; Demetrios Papahadjopoulos; Christopher C Benz
Journal:  Clin Cancer Res       Date:  2002-04       Impact factor: 12.531

7.  Human-human hybridomas secreting antibodies specific to human lung carcinoma.

Authors:  H Murakami; S Hashizume; H Ohashi; K Shinohara; K Yasumoto; K Nomoto; H Omura
Journal:  In Vitro Cell Dev Biol       Date:  1985-10
  7 in total
  1 in total

1.  Active Targeting to Osteosarcoma Cells and Apoptotic Cell Death Induction by the Novel Lectin Eucheuma serra Agglutinin Isolated from a Marine Red Alga.

Authors:  Keita Hayashi; Peter Walde; Tatsuhiko Miyazaki; Kenshi Sakayama; Atsushi Nakamura; Kenji Kameda; Seizo Masuda; Hiroshi Umakoshi; Keiichi Kato
Journal:  J Drug Deliv       Date:  2012-12-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.